Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline Transcript

PresentationWelcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this conference call is being recorded. I will now turn the call over to Ryan Crowe, Senior Vice President, Investor Relations. You may begin.Ryan CroweSenior Vice President of Investor Relations & Strategic Analysis Thank you, Shannon. Good morning, and welcome to the inaugural Regeneron Roundtable Inves ...